Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 1,083.5 million compared to CNY 770.72 million a year ago. Revenue was CNY 1,083.5 million compared to CNY 770.72 million a year ago. Net income was CNY 15.78 million compared to net loss of CNY 158.39 million a year ago. Basic earnings per share from continuing operations was CNY 0.0163 compared to basic loss per share from continuing operations of CNY 0.1639 a year ago. Diluted earnings per share from continuing operations was CNY 0.0163 compared to diluted loss per share from continuing operations of CNY 0.1639 a year ago.